# Pharmacological Prophylaxis of Post- Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis

> **NCT03708458** · PHASE4 · UNKNOWN · sponsor: **Grigore T. Popa University of Medicine and Pharmacy** · enrollment: 250 (estimated)

## Conditions studied

- Post-ERCP Pancreatitis

## Interventions

- **DRUG:** indomethacin suppository
- **DRUG:** N-acetylcysteine (NAC)

## Key facts

- **NCT ID:** NCT03708458
- **Lead sponsor:** Grigore T. Popa University of Medicine and Pharmacy
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-04-01
- **Primary completion:** 2018-12-15
- **Final completion:** 2018-12-15
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2018-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03708458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03708458, "Pharmacological Prophylaxis of Post- Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03708458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*